Home › NDC Lookup › RxCUI directory › RxCUI 2727314

3 ML onasemnogene abeparvovec-brve 40000000000000 VECTOR-GENOMES/ML Injection [Itvisma] — RxCUI 2727314

RxNorm drug concept · Semantic branded drug
RxCUI 2727314 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2727314
Official name3 ML onasemnogene abeparvovec-brve 40000000000000 VECTOR-GENOMES/ML Injection [Itvisma]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asitvisma 4 x 10(13) vg/ML per 3 ML Injection; itvisma 1.2 x 10(14) vector genomes in 3 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Onasemnogene Abeparvovec-Xioi: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zolgensma delivers a working copy of the gene your child was born without — the SMN1 gene — directly into their cells using a specially designed viral carrier. Without this gene, t...
  • What exactly does Zolgensma do for my child?
  • Yes, Zolgensma is given just once. The therapy is designed to deliver a lasting copy of the needed gene. Giving it a second time has not been studied, and it isn't recommended — in...
  • Is this really a one-time treatment? Will my child ever need it again?
📖 Read our full Onasemnogene Abeparvovec-Xioi guide →

🕸️ Concept Web — How 3 ML onasemnogene abeparvovec-brve 4000000000000... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 3 ML onasemnogene abeparvovec-brve 40000000000000 VECTOR-GENOMES/ML Injection [Itvisma] RxCUI 2727314

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Onasemnogene abeparvovec 2170226
    • Onasemnogene abeparvovec-brve 2727303
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Itvisma 2727309
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Onasemnogene abeparvovec Injection 2170229
    • Onasemnogene abeparvovec-brve Injection 2727306
    • Onasemnogene abeparvovec Injectable Product 2170228
    • Onasemnogene abeparvovec-brve Injectable Product 2727305
    • Onasemnogene abeparvovec Injection [Itvisma] 2727312
    • Onasemnogene abeparvovec-brve Injection [Itvisma] 2727313
    • Itvisma Injectable Product 2727311
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 3 ML onasemnogene abeparvovec-brve 40000000000000 VECTOR-GENOMES/ML Injection SCD · 2727307
  • Onasemnogene abeparvovec-brve 40000000000000 VECTOR-GENOMES/ML SCDC · 2727304
  • Onasemnogene abeparvovec Injection SCDF · 2170229
  • Onasemnogene abeparvovec-brve Injection SCDFP · 2727306
  • Onasemnogene abeparvovec Injectable Product SCDG · 2170228
  • Onasemnogene abeparvovec-brve Injectable Product SCDGP · 2727305

Brand-Name Concepts

  • Onasemnogene abeparvovec-brve 40000000000000 VECTOR-GENOMES/ML [Itvisma] SBDC · 2727310
  • Onasemnogene abeparvovec Injection [Itvisma] SBDF · 2727312
  • Onasemnogene abeparvovec-brve Injection [Itvisma] SBDFP · 2727313
  • Itvisma Injectable Product SBDG · 2727311
  • Itvisma BN · 2727309

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2727314 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71894-0200-02 1 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1... ITVISMA Novartis Innovative Technologies Inc. 2025-11-24
Observed labelers: Novartis Innovative Technologies Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.